FIXX - Homology Medicines Inc
Close
0.601
-0.019 -3.161%
Share volume: 322,902
Last Updated: Mon 08 Jan 2024 10:00:00 PM CET
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$0.62
-0.02
-3.07%
Summary score
22%
Profitability
0%
Dept financing
7%
Liquidity
75%
Performance
35%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Sep-2019 - 30-Sep-2023
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-13.93%
Return on assets
-12.43%
Return on sales
-3683.59%
Return on invested capital
-183.96%
Total debt ratio
21.11%
Debt ratio change over timeo
-1.51%
Current Ratio
10.52%
Quick Ratio
9.41%
Cash Position Ratio
8.64%
Short-term ratios 30-Sep-2022 - 30-Sep-2023
The data are presented for the financials results of the quarters of the last year.
Return on equity
-26.24%
Return on assets
-16.15%
Return on sales
-5478.79%
Return on invested capital
-221.85%
Total debt ratio
27.97%
Debt ratio change over timeo
-1.18%
Current Ratio
6.56%
Quick Ratio
6.56%
Cash Position Ratio
6.37%
Last quarter ratios 30-Sep-2023
The data are presented for the financials results of the last quarter.
Return on equity
-37.36%
Return on assets
-17.39%
Return on sales
0%
Return on invested capital
-405.04%
Total debt ratio
37.02%
Debt ratio change over time
-1.09%
Current Ratio
4.22%
Quick Ratio
4.22%
Cash Position Ratio
4.08%
Performance ratios (change over 4 years) 30-Sep-2019 - 30-Sep-2023
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-70.32%
Return on assets
-75.93%
Return on sales
8157.21%
Return on invested capital
135.62%
Total debt ratio
-150.63%
Debt ratio change over time
-1.51%
Current Ratio
-22.03%
Quick Ratio
-23.4%
Cash Position Ratio
-20.36%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | FIXX | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -13.93% | 0% | 0% | -117.6% |
| Return on assets | -12.43% | 0% | 0% | -11.99% |
| Return on sales | -3683.59% | 0% | 0% | -8680.79% |
| Return on invested capital | -183.96% | 0% | 0% | -48.11% |
| Profitability | 0% | 0% | 100% | 0% |
| Total debt ratio | 21.11% | 0% | 0% | 77.42% |
| Debt ratio change over time | -1.51% | 0% | 0% | -0.81% |
| Dept financing | 7% | 0% | 25% | 25% |
| Current Ratio | 6.56% | 0% | 0% | 5.35% |
| Quick Ratio | 6.56% | 0% | 0% | 5.34% |
| Cash Position Ratio | 6.37% | 0% | 0% | 5.03% |
| Liquididy | 75% | 0% | 0% | 62% |
| Short-term ratios | FIXX | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -26.24% | 0% | 0% | 146.7% |
| Return on assets | -16.15% | 0% | 0% | -18.66% |
| Return on sales | -5478.79% | 0% | 0% | -28500.29% |
| Return on invested capital | -221.85% | 0% | 0% | -371.75% |
| Profitability | 0% | 0% | 75% | 25% |
| Total debt ratio | 27.97% | 0% | 0% | 108.07% |
| Debt ratio change over time | -1.18% | 0% | 0% | -1.53% |
| Dept financing | 6% | 0% | 25% | 25% |
| Current Ratio | 6.56% | 0% | 0% | 5.35% |
| Quick Ratio | 6.56% | 0% | 0% | 5.34% |
| Cash Position Ratio | 6.37% | 0% | 0% | 5.03% |
| Liquididy | 75% | 0% | 0% | 60% |